Russell Investments Group, Ltd. - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,353,015
-25.4%
114,058
+6.8%
0.01%
-16.7%
Q2 2023$3,152,080
+66.2%
106,814
+29.8%
0.01%
+50.0%
Q1 2023$1,896,076
-31.4%
82,295
-17.2%
0.00%
-33.3%
Q4 2022$2,763,562
-15.7%
99,373
-7.0%
0.01%
-14.3%
Q3 2022$3,277,000
+26.3%
106,861
+21.1%
0.01%
+40.0%
Q2 2022$2,595,000
+56.7%
88,230
+71.3%
0.01%
+66.7%
Q1 2022$1,656,000
-43.9%
51,520
-22.1%
0.00%
-40.0%
Q4 2021$2,952,000
-10.1%
66,121
+1.2%
0.01%
-16.7%
Q3 2021$3,284,000
-34.1%
65,351
+2.5%
0.01%
-25.0%
Q2 2021$4,986,000
+82.9%
63,757
+32.9%
0.01%
+60.0%
Q1 2021$2,726,000
-59.4%
47,966
-40.1%
0.01%
-61.5%
Q4 2020$6,710,000
+243.0%
80,095
+46.7%
0.01%
+225.0%
Q3 2020$1,956,000
+48.3%
54,5990.0%0.00%
+33.3%
Q2 2020$1,319,000
+5.1%
54,599
-23.9%
0.00%0.0%
Q1 2020$1,255,000
-38.4%
71,729
-38.7%
0.00%
-25.0%
Q4 2019$2,036,000
+92.1%
116,919
+69.1%
0.00%
+100.0%
Q3 2019$1,060,000
+44.0%
69,123
+94.5%
0.00%
+100.0%
Q2 2019$736,000
+22.5%
35,540
+37.3%
0.00%0.0%
Q1 2019$601,000
+73.2%
25,890
+54.1%
0.00%0.0%
Q4 2018$347,00016,7960.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$298,165,00048.02%
Bratton Capital Management, L.P. 953,035$14,600,00028.53%
Flagship Pioneering Inc. 8,005,747$122,648,0006.71%
Casdin Capital, LLC 650,000$9,958,000,0001.03%
Temasek Holdings (Private) Ltd 4,410,457$67,568,0000.50%
MARK ASSET MANAGEMENT LP 68,864$1,055,0000.26%
IRONWOOD INVESTMENT MANAGEMENT LLC 22,507$345,0000.26%
Artal Group S.A. 400,000$6,128,0000.25%
PIER 88 INVESTMENT PARTNERS LLC 40,610$622,0000.24%
HAMILTON LANE ADVISORS LLC 30,948$474,0000.20%
View complete list of DENALI THERAPEUTICS INC shareholders